Connect with us

Savella (milnacipran)

Milnacipran (or SAVELLA, IXEL®) is mainly prescribed to treat fibromyalgia.

Status: ACTIVE

Class: Serotonin-norepinephrine reuptake inhibitor (SNRI)

FDA Approval: 2008

Dosage Forms: 12.5 mg, 25 mg, 50 mg, 100 mg

Biological Half-life: 8 hours

Side Effects: Dizziness, dry mouth, nausea, headache, constipation, insomnia, hot flush, hyperhidrosis, vomiting, tachycardia, hypertension, sexual dysfunction, increased suicide risk

Routes of Administration: Oral

Pregnancy Category: C (US)


Twitter Feed

Gene discovery may explain why Lithium doesn't work for all patients

Researchers found insomnia may increase risk of mood disorder in teens #mentalhealth @PittTweet

Can Tylenol provide relief for social media anxiety? #FOMO #socialanxiety #cyberpsychology